Back to news

BIAF jumps as fresh Japan patent news adds to CyPath Lung momentum

Investivoq PriceTracker

bioAffinity Technologies (BIAF) is up 34.7% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely catalyst is bioAffinity’s October 8 update that Japan’s patent office issued a notice of allowance for a CyPath Lung patent tied to its AI-built diagnostic method. The move also appears to be supported by momentum from the company’s October 6 announcement that CyPath Lung sales more than doubled through the third quarter of 2026, giving traders both a near-term commercialization angle and a longer-term intellectual-property story.

Details:

  • bioAffinity disclosed on October 8 that Japan intends to grant a patent covering the method used to predict lung cancer likelihood with CyPath Lung, expanding protection for the product in Asia.
  • The company said this would be its first awarded Japanese patent for CyPath Lung and part of a broader portfolio that includes 22 awarded patents and 36 pending applications.
  • Two days earlier, bioAffinity said CyPath Lung sales through the third quarter of 2026 increased more than 100% from the prior year, with 1,620 tests delivered versus 775 a year earlier.
  • The company also said the number of ordering physicians rose 89% year over year, which may have reinforced investor expectations for wider clinical adoption.

    • Sources:

    bioAffinity Technologies Investor Relations, SEC

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    Investivoq Alerts
    Receive BIAF Data Alerts
    Get market-moving data, filings, and signals for BIAF in real time.
    Sign Up

    $BIAF Hedge Fund Activity

    We have seen 12 institutional investors add shares of $BIAF stock to their portfolio, and 6 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • SABBY MANAGEMENT, LLC added 365,647 shares (+inf%) to their portfolio in Q2 2026, for an estimated $296,905
    • BLACKROCK, INC. added 98,777 shares (+inf%) to their portfolio in Q2 2026, for an estimated $80,206
    • SUSQUEHANNA INTERNATIONAL GROUP, LLP added 26,870 shares (+inf%) to their portfolio in Q2 2026, for an estimated $21,818
    • JANE STREET GROUP, LLC added 26,784 shares (+inf%) to their portfolio in Q2 2026, for an estimated $21,748
    • SCHONFELD STRATEGIC ADVISORS LLC removed 24,413 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $19,823
    • HRT FINANCIAL LP added 20,834 shares (+inf%) to their portfolio in Q2 2026, for an estimated $16,917
    • VIRTU FINANCIAL LLC added 11,113 shares (+inf%) to their portfolio in Q2 2026, for an estimated $9,023

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.